These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38712359)

  • 1. Ulcerative colitis-associated neoplasms often harbor poor prognostic histologic components with low detection by biopsy.
    Sakakibara R; Sugimoto S; Takabayashi K; Kiyohara H; Wakisaka Y; Kaieda Y; Kawaida M; Yoshimatsu Y; Sujino T; Hosoe N; Kato M; Shimoda M; Mikami Y; Iwao Y; Kanai T
    Intest Res; 2024 May; ():. PubMed ID: 38712359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
    Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort study.
    Miyakawa T; Kawamura H; Honda M; Takano Y; Kinuta S; Kamiga T; Yamazaki S; Muto A; Shiraso S; Yamashita N; Iwao T; Kono K; Konno S
    PLoS One; 2022; 17(3):e0264652. PubMed ID: 35239725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon.
    Ishihara S; Watanabe T; Akahane T; Shimada R; Horiuchi A; Shibuya H; Hayama T; Yamada H; Nozawa K; Matsuda K; Maeda K; Sugihara K
    Int J Colorectal Dis; 2012 Mar; 27(3):371-9. PubMed ID: 22052041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramucosal poorly differentiated and signet-ring cell components in patients with ulcerative colitis-associated high-grade dysplasia.
    Sugimoto S; Shimoda M; Iwao Y; Mutaguchi M; Nanki K; Mizuno S; Kameyama K; Ogata H; Naganuma M; Kanai T
    Dig Endosc; 2019 Nov; 31(6):706-711. PubMed ID: 31278777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the association of histological types and TNM stages.
    Yu J; Xin F
    Hepatogastroenterology; 2009; 56(93):1219-21. PubMed ID: 19760974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Magnifying Endoscopy with Narrow-Band Imaging for Diagnosing Mixed Poorly Differentiated Gastric Cancers.
    Inuyama M; Horiuchi Y; Yamamoto N; Yoshimizu S; Ishiyama A; Yoshio T; Hirasawa T; Tsuchida T; Igarashi Y; Fujisaki J
    Digestion; 2021; 102(6):938-945. PubMed ID: 34515095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region.
    Kanazawa T; Watanabe T; Kazama S; Tada T; Koketsu S; Nagawa H
    Int J Cancer; 2002 Nov; 102(3):225-9. PubMed ID: 12397640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of stomach cancer incidence by histologic subtypes based on a mathematical model of multistage cancer induction and exponential growth.
    Yamaguchi N; Watanabe S; Maruyama K; Okubo T
    Jpn J Cancer Res; 1990 Nov; 81(11):1109-17. PubMed ID: 2176201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.
    Konno-Shimizu M; Yamamichi N; Inada K; Kageyama-Yahara N; Shiogama K; Takahashi Y; Asada-Hirayama I; Yamamichi-Nishina M; Nakayama C; Ono S; Kodashima S; Fujishiro M; Tsutsumi Y; Ichinose M; Koike K
    PLoS One; 2013; 8(2):e56766. PubMed ID: 23451082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of endoscopic classifications for neoplastic lesions in patients with ulcerative colitis: A retrospective case-control study.
    Kida Y; Yamamura T; Maeda K; Sawada T; Ishikawa E; Mizutani Y; Kakushima N; Furukawa K; Ishikawa T; Ohno E; Kawashima H; Nakamura M; Ishigami M; Fujishiro M
    World J Gastroenterol; 2022 Mar; 28(10):1055-1066. PubMed ID: 35431498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and mutation of SMAD4 in poorly differentiated carcinoma and signet-ring cell carcinoma of the colorectum.
    Seshimo I; Yamamoto H; Mishima H; Kurata A; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Fukushima T; Tsujinaka T; Sekimoto M; Kikkawa N; Takenoshita S; Monden M
    J Exp Clin Cancer Res; 2006 Sep; 25(3):433-42. PubMed ID: 17167985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma.
    Yamamoto S; Tsuda H; Shimazaki H; Takano M; Yoshikawa T; Kuzuya K; Tsuda H; Kurachi H; Kigawa J; Kikuchi Y; Sugiyama T; Matsubara O
    Int J Gynecol Pathol; 2011 Sep; 30(5):431-41. PubMed ID: 21804390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological diagnosis of ulcerative colitis-associated neoplasia.
    Kawachi H
    Dig Endosc; 2019 Apr; 31 Suppl 1():31-35. PubMed ID: 30994228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
    Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Kato T; Yamaguchi S
    Anticancer Res; 2020 Mar; 40(3):1651-1659. PubMed ID: 32132070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma.
    Aoki R; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
    Dis Colon Rectum; 1998 Oct; 41(10):1262-72. PubMed ID: 9788390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.
    Zheng HC; Zheng YS; Xia P; Xu XY; Xing YN; Takahashi H; Guan YF; Takano Y
    Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological study of mucinous gastric carcinoma.
    Shibuya H; Nishida R; Koide S; Kurokawa J; Okita K
    Ann Chir Gynaecol; 2000; 89(4):273-6. PubMed ID: 11204957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between gastric signet-ring cell carcinoma and poorly differentiated adenocarcinoma: A comparison of histopathologic features determined by mucin core protein and trefoil factor family peptide immunohistochemistry.
    Fujimoto A; Ishikawa Y; Ishii T; Yamada A; Igarashi Y; Ohmoto Y; Kaise M
    Pathol Int; 2017 Aug; 67(8):398-403. PubMed ID: 28691258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.